Viracta Therapeutics Reports First Quarter 2023 Financial Results and Provides…
<!-- Name:DistributionId Value:8834377 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Viracta
Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference
<!-- Name:DistributionId Value:8784494 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Viracta Therapeutics Announces Orphan Drug Designation Granted by the European…
SAN DIEGO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers…